Connection
Matthew Zipse to Treatment Outcome
This is a "connection" page, showing publications Matthew Zipse has written about Treatment Outcome.
|
|
Connection Strength |
|
 |
|
 |
|
0.173 |
|
|
|
-
Zipse MM, Tzou WS. Resynchronization Therapy in Cardiac Sarcoidosis and Severe Heart Failure: When Good May Not Be Good Enough. J Cardiovasc Electrophysiol. 2017 02; 28(2):182-184.
Score: 0.049
-
Siontis KC, Winterfield JR, Zipse MM, Maher TR, Mulpuru SK, Celik MC, G?kdeniz T, Kanagasundram AN, Lin CY, Lin YJ, Chung FP, Pothineni NVK, Hyman MC, Schaller RD, Liao YW, Tzou WS, D'Avila A, Marchlinski FE, Stevenson WG, Santangeli P. Percutaneous VT Ablation Via RA-to-LV?Access in Patients With Double?Mechanical Valves: A Multicenter Registry. JACC Clin Electrophysiol. 2025 Mar; 11(3):540-550.
Score: 0.021
-
Barrett CD, Nickel A, Rosenberg MA, Ream K, Tzou WS, Aleong R, Tumolo A, Garg L, Zipse M, West JJ, Varosy P, Sandhu A. PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2023 12; 102(7):1357-1363.
Score: 0.019
-
Sabzwari SRA, Rosenberg MA, Mann J, Cerbin L, Barrett C, Garg L, Aleong RG, Sandhu A, West J, Tumolo AZ, Varosy PD, Sauer WH, Zipse MM, Tzou WS. Limitations of Unipolar Signals in Guiding Successful Outflow Tract Premature Ventricular Contraction Ablation. JACC Clin Electrophysiol. 2022 07; 8(7):843-853.
Score: 0.018
-
Siontis KC, Santangeli P, Muser D, Marchlinski FE, Zeppenfeld K, Hoogendoorn JC, Narasimhan C, Sauer WH, Zipse MM, Kapa S, Vedantham V, Rosenthal DG, Robinson MR, Patton KK, Murgatroyd F, Chicos AB, Soejima K, Roukoz H, Sacher F, Bhan A, Appelbaum J, Dickfeld T, Mankad P, Ellenbogen KA, Kron J, Kim HM, Froehlich J, Eagle KA, Bogun FM, Crawford TC. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis. JAMA Cardiol. 2022 02 01; 7(2):175-183.
Score: 0.017
-
Aleong RG, Zipse MM, Tompkins C, Aftab M, Varosy P, Sauer W, Kao D. Analysis of Outcomes in 8304 Patients Undergoing Lead Extraction for Infection. J Am Heart Assoc. 2020 04 07; 9(7):e011473.
Score: 0.015
-
Moss TJ, Zipse MM, Krantz MJ, Sauer WH, Salcedo EE, Schuller JL. Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy. Ann Noninvasive Electrocardiol. 2016 Sep; 21(5):443-9.
Score: 0.012
-
Katz DF, Turakhia MP, Sauer WH, Tzou WS, Heath RR, Zipse MM, Aleong RG, Varosy PD, Kao DP. Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):362-70.
Score: 0.011
-
Moss TJ, Krantz MJ, Zipse MM, Quaife RA, Sauer WH, Messenger JC, Groves BM, Salcedo EE, Schuller JL. Left ventricular systolic function following alcohol septal ablation for symptomatic hypertrophic cardiomyopathy. Am J Cardiol. 2014 Apr 15; 113(8):1401-4.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|